Immunomodulatory activity of IR700-labelled affibody targeting HER2.

Saved in:
Bibliographic Details
Title: Immunomodulatory activity of IR700-labelled affibody targeting HER2.
Authors: Mączyńska J; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; Department of Medical Biochemistry, Wroclaw Medical University, Wroclaw, Poland., Da Pieve C; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Burley TA; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Raes F; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Shah A; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Saczko J; Department of Molecular and Cellular Biology, Wroclaw Medical University, Wroclaw, Poland., Harrington KJ; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Kramer-Marek G; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK. gkramermarek@icr.ac.uk.
Source: Cell death & disease [Cell Death Dis] 2020 Oct 20; Vol. 11 (10), pp. 886. Date of Electronic Publication: 2020 Oct 20.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2041-4889
DOI:10.1038/s41419-020-03077-6